Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Toll-like receptor signaling: common pathways that drive cardiovascular disease and rheumatoid arthritis.

Monaco C, Terrando N, Midwood KS.

Arthritis Care Res (Hoboken). 2011 Apr;63(4):500-11. doi: 10.1002/acr.20382. Review. No abstract available.

2.

The role of toll-like receptors in rheumatoid arthritis.

Huang QQ, Pope RM.

Curr Rheumatol Rep. 2009 Oct;11(5):357-64. Review.

3.

Signal transduction in rheumatoid arthritis.

Piecyk M, Anderson P.

Best Pract Res Clin Rheumatol. 2001 Dec;15(5):789-803. Review.

PMID:
11812022
4.

Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis.

Huang Q, Pope RM.

J Leukoc Biol. 2010 Aug;88(2):253-62. doi: 10.1189/jlb.0310126. Epub 2010 May 19. Review. No abstract available.

5.

Toll-like receptor--a potent driving force behind rheumatoid arthritis.

Takagi M.

J Clin Exp Hematop. 2011;51(2):77-92. Review.

6.

Toll-like receptors in rheumatoid arthritis joint destruction mediated by two distinct pathways.

Ospelt C, Kyburz D, Pierer M, Seibl R, Kurowska M, Distler O, Neidhart M, Muller-Ladner U, Pap T, Gay RE, Gay S.

Ann Rheum Dis. 2004 Nov;63 Suppl 2:ii90-ii91. Review. No abstract available.

7.

The role of Toll-like receptor signalling in the pathogenesis of arthritis.

Brentano F, Kyburz D, Schorr O, Gay R, Gay S.

Cell Immunol. 2005 Feb;233(2):90-6. Review.

PMID:
15963480
8.

The toll-like receptor-nuclear factor kappaB pathway in rheumatoid arthritis.

Andreakos E, Sacre S, Foxwell BM, Feldmann M.

Front Biosci. 2005 Sep 1;10:2478-88. Review.

PMID:
15970510
9.

The liver X receptor pathway is highly upregulated in rheumatoid arthritis synovial macrophages and potentiates TLR-driven cytokine release.

Asquith DL, Ballantine LE, Nijjar JS, Makdasy MK, Patel S, Wright PB, Reilly JH, Kerr S, Kurowska-Stolarska M, Gracie JA, McInnes IB.

Ann Rheum Dis. 2013 Dec;72(12):2024-31. doi: 10.1136/annrheumdis-2012-202872. Epub 2013 Feb 23.

PMID:
23434566
10.

Toll-like receptor downstream signaling.

Kawai T, Akira S.

Arthritis Res Ther. 2005;7(1):12-9. Epub 2004 Nov 30. Review.

11.

Toll-like receptor signaling in the ischemic heart.

Frantz S, Ertl G, Bauersachs J.

Front Biosci. 2008 May 1;13:5772-9. Review.

PMID:
18508620
12.

SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis.

Drexler SK, Kong P, Inglis J, Williams RO, Garlanda C, Mantovani A, Yazdi AS, Brennan F, Feldmann M, Foxwell BM.

Arthritis Rheum. 2010 Aug;62(8):2249-61. doi: 10.1002/art.27517.

13.

Toll-like receptors pathways implication in common autoimmune diseases and therapeutic perspectives.

Alexoudi I, Kapsimali V, Vaiopoulos A, Kanakis M, Vaiopoulos G.

G Ital Dermatol Venereol. 2015 Apr;150(2):255-60. Review.

PMID:
25876147
14.

Hypoxia and hypoxia-inducible factor-1α provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis.

Hu F, Mu R, Zhu J, Shi L, Li Y, Liu X, Shao W, Li G, Li M, Su Y, Cohen PL, Qiu X, Li Z.

Ann Rheum Dis. 2014 May;73(5):928-36. doi: 10.1136/annrheumdis-2012-202444. Epub 2013 May 3.

PMID:
23644550
15.

Primer: Toll-like receptor signaling pathways--what do rheumatologists need to know?

O'Neill LA.

Nat Clin Pract Rheumatol. 2008 Jun;4(6):319-27. doi: 10.1038/ncprheum0802. Epub 2008 Apr 29. Review.

PMID:
18446139
16.

Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis.

McCarey D, Sturrock RD.

Clin Exp Rheumatol. 2009 Jul-Aug;27(4 Suppl 55):S124-6.

PMID:
19822058
17.

Toll-like receptor signaling: defensive or offensive for the heart?

Hori M, Nishida K.

Circ Res. 2008 Feb 1;102(2):137-9. doi: 10.1161/CIRCRESAHA.107.170225. Review. No abstract available.

18.

The emerging role of toll-like receptor pathways in surgical diseases.

Romics L Jr, Szabo G, Coffey JC, Wang JH, Redmond HP.

Arch Surg. 2006 Jun;141(6):595-601. Review.

PMID:
16785361
20.

Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).

van Beijnum JR, Buurman WA, Griffioen AW.

Angiogenesis. 2008;11(1):91-9. doi: 10.1007/s10456-008-9093-5. Epub 2008 Feb 9. Review.

PMID:
18264787
Items per page

Supplemental Content

Write to the Help Desk